Biocartis has established partnerships with major healthcare organizations and has seen significant growth in the adoption of its diagnostic solutions.
Revenue Amount
$10,000,000
ARR
$5,000,000
Organizations Involved
Major healthcare organizations and diagnostic labs.
Founders
Eddy De Geyter, Herman Verrelst
Company Description
Biocartis is a molecular diagnostics company that develops and commercializes innovative diagnostic solutions for personalized medicine. Their technology enables rapid and reliable testing for various diseases, including cancer, using a unique platform that integrates sample preparation and analysis.
Market
Healthcare Diagnostics
Location
Mechelen,
Belgium
Coinvestors
Investors include leading venture capital firms and strategic partners.